Radiopharm Theranostics (RADX)

• Market cap: $21.8M
• 1 day: -1.07%
• 5 days: -3.82%
• 1 month: -36.03%
• 3 months: -30.75%
• 6 months: -45.36%
• Year to date: -46.32%
• 1 year: -41.19%
• 5 years: -84.32%
• 10 years: -84.32%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14